SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Fountain Pharmaceuticals (FPHI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Fisner who wrote (22)8/12/1997 7:36:00 AM
From: r. peter Dale   of 78
 
Items 1 and 3 are trivial. But I guess the arguement could be made that perceptions are 50% of...perceptions in the stock biz sooo a higher priced stock and a NASDAQ listing are probably beneficial (but they still don't amount to a rat's ass).

Item #2 is D Y N O M I T E!! I'm glad you uncovered that. This tells me that, for the indefinate future, the company is most likely to have a reliable source of cash. This is a 180 degree change of status: it allows them to proceed unhindered in their research and marketing. Clearly this Wyoming group has a lot of confidence in FPHI.

This is one biotech company that is getting its science AS WELL AS its financing together. No wonder the stock has quintupled in ~10 weeks.

Best wishes,
Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext